Rhonda Ries

20PUBLICATIONS
194CO-AUTHORS
Haematological tumoursGene and molecular therapyMedical infection agents (incl. prions)Molecular targetsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 12, 2026
Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity.

|May 05, 2026
Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

|Apr 07, 2026
DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.

Lonneke Verboon, Sonali P Barwe, Meredith Tavenner

|Dec 06, 2025
Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia.

Ke Wang, Shayan Saniei, Nikita Poddar

|Nov 24, 2025
Prognostic impact of age and MDS-associated mutations in NPM1 -mutated AML.

Vivian M Liu, Megan Othus, Jasmine Naru

|Sep 08, 2025
Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma.

Michelle Choe, Danielle Kirkey, Isabel Lira

Pageof 4

Frequent Collaborators

8 joint publications

Soheil Meshinchi

5 joint publications

Xiaotu Ma

5 joint publications

Jeffery M Klco

4 joint publications

Benjamin J Huang